Hormonal therapy

International Journal of Clinical Oncology

Volumn 12, Issue 6, 2007, Pages 427-432

  Namiki, Mikio ^a   Ueno, Satoru ^a   Kitagawa, Yasuhide ^a   Konaka, Hiroyuki ^a   Mizokami, Atsushi ^a   Koh, Eitetsu ^a   Fukagai, Takashi ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Androgen; Hormonal therapy; Prostate cancer

Indexed keywords

ANTIANDROGEN; ZOLEDRONIC ACID;

ADVANCED CANCER; ANDROGEN DEPRIVATION THERAPY; ANEMIA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; FRACTURE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; THERAPY EFFECT; TREATMENT INDICATION;

ALGORITHMS; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 36949021759     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0704-8     Document Type: Review

References (21)

1. C Huggins C Hodges 1941 Studies on prostate cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Res 1 293 297
2. Cancer Registration Committee of the Japanese Urological Association 2005 Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association Int J Urol 12 46 61
3. O Maeda 2003 Option and indication for early stage prostate cancer (in Japanese) Jpn J Cancer Chemother 30 26 31
4. T Fukagai T Namiki GC Rovert 2006 Comparison of clinical outcome after hormonal therapy for prostate cancer between Japanese and Caucasian men BJU Int 97 1190 1193
5. H Akaza Y Homma M Usami 2006 Efficacy of primary hormonal therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up BJU Int 98 573 579
6. M Egawa T Misaki T Imao 2004 Retrospective study on stage B prostate cancer in the Hokuriku District, Japan Int J Urol 11 304 309
7. Y Kitagawa K Koshida A Mizokami 2003 Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy Int J Urol 10 377 382
8. CC Schulman FM Debruyne G Foster 2000 Four-year-follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer Eur Urol 38 706 713
9. F Labrie B Candas JL Gomez 2002 Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? Urology 60 115 119
10. S Ueno M Namiki T Fukagai 2006 Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: a retrospective multicenter study Int J Urol 13 1494 1500
11. AV D'Amico R Whittington SB Malkowicz 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969 974
12. JE Johansson O Andren SO Andersson 2004 Natural history of early, localized prostate cancer JAMA 291 2713 2719
13. F Labrie A Belanger V Lun-The 2002 Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease Mol Cell Endocr 198 77 87
14. MV Meng EP Elkin SR Harlan 2003 Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE J Urol 170 2279 2283
15. N Tanaka H Hara F Yamabe 2005 Investigation on prostate re-biopsy and high-sensitivity PSA of prostate cancer patients receiving endocrine therapy (in Japanese) Jpn J Urol 96 196
16. K Akakura H Ito N Sato 2000 Intermittent androgen suppression for prostate cancer (in Japanese) Nippon Rinsho 58 Suppl 289 291
17. A Mizokami S Ueno T Fukagai 2007 Global update on defining and treating high-risk localizing prostate cancer with leuprolin: an Asian perspective BJU Int 99 Suppl 6 9
18. T Kato A Komiya H Suzuki 2007 Effect of androgen deprivation therapy on quality of life in Japanese men with prostate cancer Int J Urol 14 416 421
19. MR Smith J Eastham DM Gleason 2003 Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer J Urol 169 2008 2012
20. H Akaza F Labrie M Namiki 2007 A way of thinking of a MAB therapy for local/locally advanced prostate cancer: the theory and recent evaluation (in Japanese) Jpn J Cancer Chemother 34 657 669
21. IJ Korfage HJ deKoning DF Habbema 2007 Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls? BJU Int 99 801 806